Ac-Gly-BoroPro
>98%
- Product Code: 105890
CAS:
886992-99-0
| Molecular Weight: | 214.03 g./mol | Molecular Formula: | C₈H₁₅BN₂O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Ac-Gly-BoroPro is primarily utilized in the field of medicinal chemistry and biochemistry as a potent and selective inhibitor of proteases, particularly dipeptidyl peptidase IV (DPP-IV). Its boronic acid moiety enables it to form stable covalent interactions with the active site of the enzyme, making it a valuable tool for studying enzyme mechanisms and inhibition. This compound is often employed in research to investigate the role of DPP-IV in various physiological processes, including glucose metabolism and immune regulation. Additionally, it serves as a key structural template for the development of therapeutic agents targeting DPP-IV, which is relevant in the treatment of type 2 diabetes and other metabolic disorders. Its application extends to drug discovery programs where it aids in the optimization of inhibitor potency and selectivity.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿32,600.00 |
+
-
|
Ac-Gly-BoroPro
Ac-Gly-BoroPro is primarily utilized in the field of medicinal chemistry and biochemistry as a potent and selective inhibitor of proteases, particularly dipeptidyl peptidase IV (DPP-IV). Its boronic acid moiety enables it to form stable covalent interactions with the active site of the enzyme, making it a valuable tool for studying enzyme mechanisms and inhibition. This compound is often employed in research to investigate the role of DPP-IV in various physiological processes, including glucose metabolism and immune regulation. Additionally, it serves as a key structural template for the development of therapeutic agents targeting DPP-IV, which is relevant in the treatment of type 2 diabetes and other metabolic disorders. Its application extends to drug discovery programs where it aids in the optimization of inhibitor potency and selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :